Sotera Health (SHC) Expected to Announce Earnings on Thursday

Sotera Health (NASDAQ:SHC) is anticipated to announce its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect Sotera Health to announce earnings of $0.2389 per share and revenue of $309.6980 million for the quarter. Individuals can find conference call details on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, August 6, 2026 at 9:00 AM ET.

Sotera Health (NASDAQ:SHC) last posted its earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The company had revenue of $280.05 million for the quarter, compared to the consensus estimate of $270.78 million. During the same quarter in the previous year, the business earned $0.14 earnings per share. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. On average, analysts expect Sotera Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Sotera Health Stock Performance

Shares of Sotera Health stock opened at $18.11 on Wednesday. The firm has a market cap of $5.16 billion, a PE ratio of 44.17 and a beta of 1.77. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56. Sotera Health has a 52 week low of $11.00 and a 52 week high of $19.85. The business’s fifty day simple moving average is $16.96 and its 200-day simple moving average is $16.32.

Insider Activity

In related news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of Sotera Health stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 15.36% of the company’s stock.

Institutional Investors Weigh In On Sotera Health

Large investors have recently bought and sold shares of the stock. Empowered Funds LLC grew its position in shares of Sotera Health by 11.1% during the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock worth $332,000 after buying an additional 2,845 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Sotera Health by 14.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock valued at $3,999,000 after acquiring an additional 43,471 shares in the last quarter. Acadian Asset Management LLC lifted its stake in Sotera Health by 125.5% in the first quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock worth $293,000 after acquiring an additional 14,018 shares during the last quarter. Creative Planning lifted its stake in Sotera Health by 15.3% in the second quarter. Creative Planning now owns 20,186 shares of the company’s stock worth $224,000 after acquiring an additional 2,673 shares during the last quarter. Finally, Invesco Ltd. grew its holdings in Sotera Health by 4.2% during the 2nd quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock worth $3,549,000 after acquiring an additional 12,758 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on SHC. Wall Street Zen lowered shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Barclays boosted their price target on shares of Sotera Health from $18.00 to $19.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. Piper Sandler restated an “overweight” rating and issued a $22.00 price objective (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Weiss Ratings raised shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Finally, UBS Group set a $19.00 target price on shares of Sotera Health in a report on Wednesday, June 24th. Eight research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, Sotera Health currently has a consensus rating of “Moderate Buy” and an average price target of $20.25.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.